{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:02:27Z","timestamp":1760299347918},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Scientific Foundation of China","doi-asserted-by":"publisher","award":["81273595","81202594","81001445","81373490","81522048","81573511"],"award-info":[{"award-number":["81273595","81202594","81001445","81373490","81522048","81573511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special Topic of the Major Subject of National Science and Technology","award":["2013ZX09509-107"],"award-info":[{"award-number":["2013ZX09509-107"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jphs.2016.04.016","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T16:14:02Z","timestamp":1461946442000},"page":"244-248","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers"],"prefix":"10.1016","volume":"132","author":[{"given":"Guojing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiagen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2016.04.016_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2016.04.016_bib2","doi-asserted-by":"crossref","first-page":"b1668","DOI":"10.1136\/bmj.b1668","article-title":"Guideline Development G. Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance","volume":"338","author":"Adler","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jphs.2016.04.016_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4254\/wjh.v6.i4.199","article-title":"Insulin sensitizers for the treatment of non-alcoholic fatty liver disease","volume":"6","author":"Ozturk","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jphs.2016.04.016_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(02)07566-9","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"359","author":"Urso","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2016.04.016_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2016.04.016_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2016.04.016_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1095\/biolreprod.110.087023","article-title":"Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA)","volume":"84","author":"Tosca","year":"2011","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jphs.2016.04.016_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1254\/jphs.93.501","article-title":"Metformin protects against carbon tetrachloride hepatotoxicity in mice","volume":"93","author":"Poon","year":"2003","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2016.04.016_bib9","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3892\/ijo.2015.2903","article-title":"Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in\u00a0vitro and in\u00a0vivo","volume":"46","author":"Fujihara","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jphs.2016.04.016_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7314\/APJCP.2015.16.2.595","article-title":"Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis","volume":"16","author":"Hwang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jphs.2016.04.016_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.jphs.2016.04.016_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/mol.51.6.913","article-title":"Cloning and functional expression of a human liver organic cation transporter","volume":"51","author":"Zhang","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2016.04.016_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cpt1978246683","article-title":"Disposition of metformin (N,N-dimethylbiguanide) in man","volume":"24","author":"Sirtori","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jphs.2016.04.016_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40262-015-0270-6","article-title":"A\u00a0comprehensive review of drug\u2013drug interactions with metformin","volume":"54","author":"Stage","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jphs.2016.04.016_bib15","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jm2001629","article-title":"Profiling of a prescription drug library for potential renal drug\u2013drug interactions mediated by the organic cation transporter 2","volume":"54","author":"Kido","year":"2011","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jphs.2016.04.016_bib16","doi-asserted-by":"crossref","first-page":"e22163","DOI":"10.1371\/journal.pone.0022163","article-title":"Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)","volume":"6","author":"Nies","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2016.04.016_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2016.04.016_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2013.08.024","article-title":"Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs)","volume":"273","author":"Li","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jphs.2016.04.016_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jphs.2016.04.016_bib20","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.2337\/db13-1367","article-title":"Metformin pharmacogenomics: current status and future directions","volume":"63","author":"Pawlyk","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2016.04.016_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1208\/s12248-013-9460-z","article-title":"Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects","volume":"15","author":"Yoon","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.jphs.2016.04.016_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FPC.0b013e32833fe789","article-title":"Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin","volume":"20","author":"Chen","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jphs.2016.04.016_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/dmd.113.055616","article-title":"Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics","volume":"42","author":"Kim","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jphs.2016.04.016_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00228-013-1604-7","article-title":"The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects","volume":"70","author":"Ding","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jphs.2016.04.016_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jphs.2016.04.016_bib26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/009127009603601105","article-title":"Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus","volume":"36","author":"Sambol","year":"1996","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jphs.2016.04.016_bib27","first-page":"149","article-title":"Effect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT2) in Sprague\u2013Dawley rats","volume":"25","author":"Gao","year":"2013","journal-title":"Shanghai Arch Psychiatry"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316300330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316300330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T04:35:57Z","timestamp":1567830957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861316300330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1347861316300330"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2016.04.016","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2016.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}